These findings indicate that ABHD5 negatively regulates c-MYC-driven transcriptional programs by suppressing c-MYC protein expression and suggest a novel tumor-suppressive mechanism in prostate cancer cells. The gene discussed is ABHD5; the disease is prostate carcinoma.